Interpace Biosciences Inc (IDXG)
1.47
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Interpace Biosciences Shareholders Equity (Quarterly): -61.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -61.67M |
September 30, 2023 | -62.68M |
June 30, 2023 | -62.21M |
March 31, 2023 | -62.54M |
December 31, 2022 | -63.07M |
September 30, 2022 | -61.59M |
June 30, 2022 | -47.95M |
March 31, 2022 | -44.34M |
December 31, 2021 | -42.42M |
September 30, 2021 | -38.65M |
June 30, 2021 | -35.79M |
March 31, 2021 | -32.90M |
December 31, 2020 | -29.08M |
September 30, 2020 | -21.80M |
June 30, 2020 | 1.693M |
March 31, 2020 | 6.838M |
December 31, 2019 | 21.69M |
September 30, 2019 | 23.60M |
June 30, 2019 | 30.83M |
March 31, 2019 | 35.77M |
December 31, 2018 | 15.45M |
September 30, 2018 | 36.03M |
June 30, 2018 | 38.55M |
March 31, 2018 | 39.76M |
December 31, 2017 | 39.87M |
Date | Value |
---|---|
September 30, 2017 | 36.38M |
June 30, 2017 | 36.34M |
March 31, 2017 | 24.57M |
December 31, 2016 | 6.531M |
September 30, 2016 | -1.479M |
June 30, 2016 | 5.993M |
March 31, 2016 | 8.306M |
December 31, 2015 | 13.04M |
September 30, 2015 | 5.861M |
June 30, 2015 | 10.30M |
March 31, 2015 | 16.62M |
December 31, 2014 | 20.12M |
September 30, 2014 | 25.42M |
June 30, 2014 | 29.35M |
March 31, 2014 | 31.34M |
December 31, 2013 | 32.48M |
September 30, 2013 | 36.01M |
June 30, 2013 | 37.72M |
March 31, 2013 | 37.88M |
December 31, 2012 | 35.63M |
September 30, 2012 | 59.18M |
June 30, 2012 | 59.74M |
March 31, 2012 | 59.57M |
December 31, 2011 | 59.52M |
September 30, 2011 | 69.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-63.07M
Minimum
Dec 2022
30.83M
Maximum
Jun 2019
-30.63M
Average
-38.65M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 163.89M |
XWELL Inc | 13.00M |
ProPhase Labs Inc | 49.38M |
Applied DNA Sciences Inc | 4.232M |
Veracyte Inc | 1.044B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.02M |
Total Liabilities (Quarterly) | 74.69M |
Debt to Equity Ratio | -0.1515 |
Current Ratio | 0.5907 |
Net Debt Paydown Yield | 12.51% |